Citius Oncology Reports 120% Growth in LYMPHIR Shipments
Citius Oncology reported 120% growth in shipments of LYMPHIR units to U.S. wholesalers during fiscal fourth-quarter 2026 and continued institutional demand.
Citius Oncology reported 120% growth in shipments of LYMPHIR units to U.S. wholesalers during fiscal fourth-quarter 2026 and continued institutional demand.